 FARMINGTON HILLS, Mich., June 11, 2021 GLOBE NEWSWIRE -- Ocuphire Pharma, Inc. Nasdaq: OCUP, a clinical-stage ophthalmic biopharmaceutical company focused on development and commercialization of therapies for the treatment of several eye disorders, today announced that the Company is set to join the Russell Microcap Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, 2021, according to a preliminary list of additions posted June 4, 2021. 